Stockscreener 앱 받기
14.94
5.90%
-0.91
전일 마감가:
$15.85
열려 있는:
$15.43
하루 거래량:
254.09K
Relative Volume:
0.31
시가총액:
$591.43M
수익:
$128.29M
순이익/손실:
$-30.69M
주가수익비율:
-18.22
EPS:
-0.82
순현금흐름:
$-27.17M
1주 성능:
+2.44%
1개월 성능:
-8.27%
6개월 성능:
-71.17%
1년 성능:
-75.82%
1일 변동 폭
$14.90
$15.82
1주일 범위
$14.43
$16.02
52주 변동 폭
$13.50
$66.54
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
RXST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
14.92 | 591.43M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.12 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.45 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.66 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.34 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.36 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 개시 | Piper Sandler | Neutral |
| 2025-04-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-04 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-04-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-10-29 | 개시 | Jefferies | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-05-07 | 재확인 | BTIG Research | Buy |
| 2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 개시 | Morgan Stanley | Overweight |
| 2023-04-13 | 개시 | Oppenheimer | Outperform |
| 2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight (RXST) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (RXST) - news.stocktradersdaily.com
Prepare Yourself for Liftoff: RxSight Inc (RXST) - Sete News
RxSight Inc (RXST)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
RxSight Inc (RXST) is a good investment, but the stock may be undervalued - uspostnews.com
RxSight, Inc. to Present at the Bank of America Healthcare Conference - The Manila Times
RxSight, Inc. to Present at Bank of America Healthcare Conference on May 14, 2025 - Nasdaq
RxSight Brings Latest Cataract Surgery Innovation Updates to Major Healthcare Conference - Stock Titan
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com
Russell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
JPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of “Hold” by Brokerages - Defense World
RxSight Inc [RXST] Records 50-Day SMA of $23.43 - knoxdaily.com
What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate? - Yahoo
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
RxSight, Leading Eye Surgery Tech Company, Sets Q1 2025 Earnings Release Date - Stock Titan
LPL Financial LLC Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Geode Capital Management LLC Has $28.57 Million Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Piper Sandler Initiates Coverage of RxSight (RXST) with Neutral Recommendation - Nasdaq
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga
Piper Sandler Initiates RxSight at Neutral With $18 Price Target - marketscreener.com
Piper Sandler Begins Coverage of RxSight (RXST) with Neutral Rat - GuruFocus
Piper Sandler sets RxSight stock target at $18, stays neutral By Investing.com - Investing.com South Africa
Piper Sandler sets RxSight stock target at $18, stays neutral - Investing.com
Piper Sandler Starts RxSight Inc. (RXST) at Neutral - StreetInsider
RxSight price target lowered to $17 from $22 at Wells Fargo - MSN
Midday Stock Roundup: BJ’s Restaurants Beats Estimates - Orange County Business Journal
RxSight plunges after guidance cut; BofA downgrades - MSN
RxSight stock plunges to 52-week low at $14.24 amid market challenges By Investing.com - Investing.com South Africa
RxSight stock plunges to 52-week low at $14.24 amid market challenges - Investing.com
UBS cuts RxSight stock rating to neutral, slashes price target to $16 By Investing.com - Investing.com South Africa
RxSight downgraded at UBS after Q1 miss and guidance cut - MSN
RxSight stock downgraded at UBS on guidance cut (RXST:NASDAQ) - Seeking Alpha
Needham Cuts Price Target on RxSight to $22 From $43, Keeps Buy Rating - MarketScreener
UBS Downgrades RxSight to Neutral From Buy, Cuts Price Target to $16 From $45 - MarketScreener
UBS cuts RxSight stock rating to neutral, slashes price target to $16 - Investing.com Australia
UBS Downgrades RxSight Inc. (RXST) to Neutral - StreetInsider
RxSight at Needham Conference: Strategic Adjustments Amid Market Challenges By Investing.com - Investing.com Canada
Analysts Are Neutral on Top Healthcare Stocks: RxSight (RXST), Johnson & Johnson (JNJ) - The Globe and Mail
Needham & Company LLC Reiterates “Buy” Rating for RxSight (NASDAQ:RXST) - Defense World
Rxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challenges - MSN
Midday Stock Roundup: Masimo, Virgin Galactic an Others Take Dives - Orange County Business Journal
JP Morgan downgrades RxSight on market, competitive pressures - Investing.com
JPMorgan Downgrades RxSight to Underweight From Overweight, Adjusts Price Target to $17 From $40 - MarketScreener
Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) - Benzinga
RxSight Faces Market Challenges As Revenue Guidance Drops - Finimize
RxSight’s preliminary Q1 2025 revenue expected to increase 28% - Medical Buyer
American Express, Rxsight, Vertiv Holdings - TradingView
RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... By GuruFocus - Investing.com Canada
JPMorgan Double Downgrades RxSight Inc. (RXST) to Underweight - StreetInsider
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.16%
자본화:
|
볼륨(24시간):